Page 222 - Handbook of Deep Learning in Biomedical Engineering Techniques and Applications
P. 222

212   Chapter 7 Early detection and diagnosis using deep learning




                                    3.3 Autism spectrum disorder
                                      Standardized tests that give out conclusive results to a patient
                                    for their respective treatment have been the gold standard for
                                    curing a person. However, they fail to meet the requirements
                                    for a vast array of mental disorders. Autism spectrum disorder
                                    (ASD) is a neurodevelopment disorder that is near impossible
                                    to single out in its early stages, especially in the case of children.
                                    Unlike biological tests that are quantitative, mental disorders rely
                                    primarily on behavioral symptomology and are hence vulnerable
                                    to misdiagnosis. The issue lies with a multitude of symptoms
                                    shown by mental disorders that closely or entirely resemble
                                    symptoms of other disorders. ASD is a lifelong disorder that
                                    causes various impediments to everyday life, and with over 1%
                                    of children showing signs, it is imperative that it is treated head
                                    on in its early stages.
                                       ASD shows unique behavioral symptomology and leads to the
                                    development of distinguishable repetitive actions. When these
                                    are monitored along with the analysis of brain data, possible
                                    quantitative means to identifying ASD may be discovered. This
                                    is where DL comes in. With mass analysis of information from
                                    population demographics and brain scans that show ASD, bio-
                                    markers could be developed that shows researchers reliable signs
                                    of development of mental disorders. Hence, moving forward with
                                    this task requires advancements in scalable DL infrastructure.
                                       The algorithms that analyze data in DL can avoid strict catego-
                                    rization due to their unprecedented nature of unsupervised
                                    learning. DL is able to make its own categories that rely on min-
                                    imal human interaction, resulting in the extraction of data that
                                    the machine feels are relevant. This allows for classification at a
                                    more intrinsic level due to unsupervised access into clinical
                                    data sets. This vastly differs from supervised learning. Supervised
                                    learning methods involve associating the learner to a specific
                                    label or tag using which the classifier sorts data. With this step
                                    removed, unsupervised learners have the capacity to explore
                                    demographics, brain analysis, and big data sets and form classi-
                                    fiers of their own. This results in biomarkers for all types of
                                    mental disorders that are less susceptible to errors.
                                       Research into ASD, thus far using MRI, shows clear signs both
                                    structurally and functionally in brain imaging of patients with
                                    ASD. MRI scans reveal that individuals exhibiting ASD show an
                                    age-related brain growth abnormality in the frontal section,
                                    making it imperative that ASD is identified in its initial stages.
                                    From this, we have been able to identify, for the most part,
                                    patients showing ASD; however, due to the complexity and lack
   217   218   219   220   221   222   223   224   225   226   227